Pelin Mutlu
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 5
- DNA Repair Mechanisms 4
- Oncology 9
- Cancer-related Molecular Pathways 3
- Co-authors
- Ufuk Gündüz (26 shared papers)Serap Yalçın (14 shared papers)Gözde Ünsoy (10 shared papers)Rouhollah Khodadust (8 shared papers)Ayşen Tezcaner (2 shared papers)Önder Öngürü (1 shared paper)Ali Uğur Ural (4 shared papers)Güngör Gündüz (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (4 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)ACS Omega (2 papers)Journal of Nanoparticle Research (2 papers)Cancer Investigation (1 paper)
- Partner nations
- TürkiyeUnited StatesSerbia
In The Last Decade
Pelin Mutlu
36 papers receiving 899 citations
Peers
Comparison fields: 5 of 86
- Biomaterials 479
- Pharmaceutical Science 110
- Molecular Medicine 65
- Polymers and Plastics 163
- Biomedical Engineering 326
Countries citing papers authored by Pelin Mutlu
This map shows the geographic impact of Pelin Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pelin Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pelin Mutlu more than expected).
Fields of papers citing papers by Pelin Mutlu
This network shows the impact of papers produced by Pelin Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pelin Mutlu. The network helps show where Pelin Mutlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pelin Mutlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 290 | |
| 2 | 2014 | 113 | |
| 3 | 2016 | 95 | |
| 4 | 2014 | 65 | |
| 5 | 2014 | 65 | |
| 6 | 2013 | 45 | |
| 7 | 2016 | 37 | |
| 8 | 2014 | 26 | |
| 9 | 2024 | 19 | |
| 10 | 2020 | 17 | |
| 11 | 2009 | 16 | |
| 12 | 2012 | 13 | |
| 13 | Poly(amidoamine) (PAMAM) Nanoparticles: Synthesis and Biomedical Applications | 2013 | 13 |
| 14 | 2015 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2023 | 8 | |
| 17 | Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations. | 2015 | 8 |
| 18 | 2015 | 8 | |
| 19 | 2011 | 7 | |
| 20 | 2014 | 6 |
About Pelin Mutlu
Pelin Mutlu is a scholar working on Molecular Biology, Oncology, Biomaterials, Polymers and Plastics and Biomedical Engineering, having authored 38 papers that have together received 916 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (5 papers), Dendrimers and Hyperbranched Polymers (5 papers), DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (3 papers), Graphene and Nanomaterials Applications (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Click Chemistry and Applications (2 papers). The work is most often cited by research in Biomaterials (479 citations), Pharmaceutical Science (110 citations), Molecular Medicine (65 citations), Polymers and Plastics (163 citations) and Biomedical Engineering (326 citations). Pelin Mutlu has collaborated with scholars based in Türkiye, United States and Serbia. Frequent co-authors include Ufuk Gündüz, Serap Yalçın, Gözde Ünsoy, Rouhollah Khodadust, Ayşen Tezcaner, Önder Öngürü, Ali Uğur Ural, Güngör Gündüz, Yusuf Baran and Arzu Yakar. Their work appears in journals such as Biomedicine & Pharmacotherapy, Anti-Cancer Agents in Medicinal Chemistry, ACS Omega, Journal of Nanoparticle Research and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.